Australia markets closed

American Healthcare REIT, Inc. (AHR)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
14.76-0.14 (-0.94%)
At close: 04:00PM EDT
14.99 +0.23 (+1.56%)
After hours: 05:35PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.94B
Enterprise value 4.11B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.59
Price/book (mrq)0.99
Enterprise value/revenue 2.16
Enterprise value/EBITDA 12.25

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 311.65%
S&P500 52-week change 324.96%
52-week high 315.34
52-week low 312.63
50-day moving average 314.17
200-day moving average 313.97

Share statistics

Avg vol (3-month) 3903.25k
Avg vol (10-day) 31.25M
Shares outstanding 565.37M
Implied shares outstanding 6119.61M
Float 8130.25M
% held by insiders 11.30%
% held by institutions 1106.05%
Shares short (31 May 2024) 4774.1k
Short ratio (31 May 2024) 41
Short % of float (31 May 2024) 41.36%
Short % of shares outstanding (31 May 2024) 40.59%
Shares short (prior month 30 Apr 2024) 41.11M

Dividends & splits

Forward annual dividend rate 41
Forward annual dividend yield 46.78%
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 319 July 2024
Ex-dividend date 427 June 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -2.60%
Operating margin (ttm)5.29%

Management effectiveness

Return on assets (ttm)1.05%
Return on equity (ttm)-2.80%

Income statement

Revenue (ttm)1.9B
Revenue per share (ttm)25.18
Quarterly revenue growth (yoy)10.30%
Gross profit (ttm)N/A
EBITDA 291.96M
Net income avi to common (ttm)-49.49M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)82.52M
Total cash per share (mrq)0.63
Total debt (mrq)2.25B
Total debt/equity (mrq)104.94%
Current ratio (mrq)0.67
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)68.72M
Levered free cash flow (ttm)128.61M